DISC1 Conditioned GWAS for Psychosis Proneness in a Large Finnish Birth Cohort by Tomppo, Liisa et al.
DISC1 Conditioned GWAS for Psychosis Proneness in a
Large Finnish Birth Cohort
Liisa Tomppo1,2, Jesper Ekelund2,3,4, Dirk Lichtermann5, Juha Veijola6, Marjo-Riitta Ja¨rvelin7, William
Hennah1,2,8*
1 Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland, 2National Institute for Health and Welfare, Helsinki, Finland, 3Department of
Psychiatry, University of Helsinki, Helsinki, Finland, 4Vaasa Hospital District, Vaasa, Finland, 5Cafe´ Ersatz, Bonn, Germany, 6Department of Psychiatry, University of Oulu,
Oulu, Finland, 7Department of Epidemiology and Public Health, Imperial College, London, United Kingdom, 8Medical Genetics Section, University of Edinburgh,
Edinburgh, United Kingdom
Abstract
Background: Genetic evidence implicates the DISC1 gene in the etiology of a number of mental illnesses. Previously, we
have reported association between DISC1 and measures of psychosis proneness, the Revised Social Anhedonia Scale (RSAS)
and Revised Physical Anhedonia Scale (RPAS), in the Northern Finland Birth Cohort 1966 (NFBC66). As part of the studies of
this Finnish birth cohort genome-wide association analysis has recently been performed.
Methodology: In the present study, we re-analyzed the genome-wide association data with regard to these two measures
of psychosis proneness, conditioning on our previous DISC1 observation. From the original NFBC66 sample (N = 12 058),
4 561 individuals provided phenotype and genotype data. No markers were significant at the genome-wide level. However,
several genes with biological relevance to mental illnesses were highlighted through loci displaying suggestive evidence for
association ($3 SNP with P,10E-4). These included the protein coding genes, CXCL3, KIAA1128, LCT, MED13L, TMCO7, TTN,
and the micro RNA MIR620.
Conclusions: By conditioning a previous genome-wide association study on DISC1, we have been able to identify eight
genes as associating to psychosis proneness. Further, these molecules predominantly link to the DISC1 pathway,
strengthening the evidence for the role of this gene network in the etiology of mental illness. The use of quantitative
measures of psychosis proneness in a large population cohort will make these findings, once verified; more generalized to a
broad selection of disorders related to psychoses and psychosis proneness.
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Introduction
Disrupted in Schizophrenia 1 (DISC1) is one of the most
promising candidate genes for schizophrenia with abundant
supporting evidence from linkage, association, gene expression
studies and animal models (for review see [1]). In order to follow-
up the prior identification that three DISC1 SNPs (rs821577,
rs821633 and rs1538979) modify risk to schizophrenia and bipolar
disorder dependent on interplay [2], we studied these SNPs in
relation to four psychometric scales evaluated in the Northern
Finland Birth Cohort 1966 (NFBC66). We noted that the three
SNPs significantly affect population wide measures of psychosis
proneness [3], significantly modifying scores of Revised Social
Anhedonia Scale (RSAS) and Revised Physical Anhedonia Scale
(RPAS) through interplay. RSAS and RPAS are characteristic
symptoms of schizophrenia, in their severe forms they describe an
individual’s incapability to appreciate physical pleasure (physical
anhedonia) or social contact (social anhedonia). Individuals scoring
high in these dimensions are assumed to bear a behavioral
endophenotype [4] that increases their risk to develop overt
psychotic syndromes, and indeed follow-up investigations of the
original cohorts have provided evidence of varying degree for the
presence of these behavioral traits [5].
In addition to DISC1, a number of genes encoding proteins that
interact with DISC1 have emerged as promising candidate genes
for schizophrenia and other major mental illnesses [1]). As a result,
the concept of the DISC1 pathway has been proposed. This
hypothesis proposes that in addition to disruption of DISC1, the
disruption of other genes in the pathways DISC1 is involved in
could also increase risk to mental illness [6]. One key study in this
DISC1 pathway hypothesis was the identification of NDE1. The
NDE1 gene only came to light when we re-analyzed our genome-
wide linkage data conditioned on a DISC1 associating risk
haplotype [7]. In that study, families with the risk allele of DISC1
and those without were treated as two separate sample sets
hypothesizing that since locus heterogeneity certainly exists
between families, this ascertainment strategy could provide some
added power, through reducing this genetic heterogeneity, to
identify genes involved in the molecular pathogenesis of
schizophrenia. Although none of the identified conditioned linkage
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peaks reached significance, a number of defined peaks were
observed at genomic regions previously strongly implicated in
schizophrenia and/or bipolar disorder [7]. One such peak was at
chromosome 16p13 close to NDE1 which in a follow-up analysis
revealed significant association to schizophrenia in Finnish families
ascertained for schizophrenia [7]. Since this observation, NDE1
has been implicated in the etiology of schizophrenia in several
studies world wide (for review [8]).
In the present study, we exploited the conditioned approach
and performed a genome-wide association study (GWAS) on
RSAS and RPAS dependent on the DISC1 variants previously
detected to associate with these traits. In the unconditioned
genome-wide association study of the four psychometric scales, no
significant association was detected to RSAS or RPAS (Ekelund et
al 2011, in preparation). We hypothesized that through stratifica-
tion based on the significant DISC1 variants, we are more likely to
identify; due to increased homogeneity in the stratified samples;
variants of small effect size that have direct biological relevance to
psychosis proneness and potentially interact with DISC1.
Results
A total of eight genome-wide association scans have been
performed using different models and phenotypes. No markers
reached the genome-wide significance level of P,5E-8, under any
of the models tested. However, using the criteria of at least three
SNPs (within a 300 kb genomic region) displaying P,10E-4, 18
clusters of suggestive evidence were observed (Figure S1).
Both coding (Table S1) and non-coding genes were identified at
these clusters. These were studied for relevance to the DISC1
pathway. A total of 24 genes and 2 micro RNAs were identified at
the 18 loci. Of these, seven genes had prior evidence for
involvement with the DISC1 pathway. Two genes were observed
that directly interact with DISC1, CCDC141 (2q31.2) which binds
to the DISC1 protein [9] and LCT (2q21.3) which has been noted
to have significantly increased expression in carriers of a certain
DISC1 genotype [10]. Three genes were noted to bind to
previously known DISC1 interactors, TTN (2q31.2) interacts with
ACTN1 and ACTN2 [6], KIAA1128 (FAM190B) (10q23.1) interacts
with NDE1, NDEL1, EXOC1 and SYNE1 [11], while TMCO7
(16q22.1) binds MACF1 [12]. Additionally, two genes are
regulated at the gene expression level by DISC1 binding partners,
CXCL3 (4q13.3,) by APP and MED13L (12q24.21) by ATF4
[13,14] (Table 1, Figure 1, Table S2).
In addition to the coding genes, the two miRNAs identified
within the cluster regions were studied further through in silico
techniques. This focused on the identification of genes that are
reported to be targeted by the micro RNAs, and then testing these
target genes for biological, functional or pathway enrichment.
MIR620 has predicted target sites in 896 genes with the most
statistically enriched category of these genes in IPA being for genes
previously implicated in bipolar disorder (66 molecules; P = 1.93E-
05). The second most enriched category was psychological
disorders (93 molecules; P = 2.19E-05) (Table S3). A number of
the genes in these categories, including LCT, have been previously
directly implicated in the etiology of schizophrenia and psychosis
(Figure S2). The 1 093 predicted target sites of MIR128-1 did not
display principal enrichment in pathways related to central
nervous system or mental illnesses (Table S4). The most significant
categories were related to cancer (histiocytic sarcoma, P= 6.03E-
05) while the most significant category related to nervous system
development ranked as 158th and was ‘‘size of forebrain’’ (2
molecules, P = 4.50E-03).
Discussion
In this study we have re-analyzed our GWAS data for psychosis
proneness measures in a large Finnish birth cohort. Performing
DISC1 conditioned GWAS for the quantitative traits Revised
Social Anhedonia Scale (RSAS) and Revised Physical Anhedonia
Scale (RPAS). No genome wide significance was observed.
However, six loci displayed suggestive evidence for association,
in the form of association clusters, and biological relevance. These
loci were on chromosomes 2q21.3 (LCT), 2q31.2 (CCDC141,
TTN), 4q13.3 (CXCL3), 10q23.1 (KIAA1128), 12q24.21 (MED13L,
MIR620), and 16q22.1 (TMCO7).
The majority of the identified protein coding genes are yet to be
fully characterized, CCDC141, KIAA1128, CXCL3 and TMCO7.
However, the proteins of these genes have been previously linked
to the DISC1 pathway through binding DISC1 itself or one of its
interacting partners [6,10–14]. Of those genes that have been
further characterized MED13L, whose expression levels are
regulated by the DISC1 binding partner ATF4, has been
implicated in brain and heart development [15]. The TTN gene
codes for a protein expressed in striated and cardiac muscles which
regulates the length of sarcomeres [16,17], while the LCT gene is
well known to encode the enzyme that metabolizes lactose. This
latter observation initially provokes an obvious question, since LCT
has been previously suggested to be an indicator for population
stratification, due to a large variation of allele frequencies across
different populations [18]. However, in a previous study, it was
shown that within this sample there was no evidence for
population stratification [19]. Further, if population stratification
was present we would expect to notice non-normally distributed
QQ plots. We observed no notable deviation from the significance
level expected by chance in this study (Figure S3).
Table 1. Summary of the associated genes with biological relevance for schizophrenia or the DISC1 pathway.
Chr Position (kb) Model
SNPs
P,1E-4 Best SNP
Best SNP
P-value
Number
of genes
Number of
miRNA’s
Biologically
relevant targets
2q21.3 136126–136361 RPAS risk 5 rs4954633 1.84E-06 3 0 LCT
2q31.2 179169–179462 RPAS covariated 3 rs2046778 1.67E-05 2 0 CCDC141, TTN
4q13.3 75104–75219 RSAS covariated 3 rs9131 3.43E-05 2 0 CXCL3
10q23.1 86142–86298 RPAS risk 4 rs10509494 5.36E-05 1 0 KIAA1128
12q24.21 114894–115222 RPAS neutral 3 rs11615689 2.24E-06 1 1 MED13L, MIR620
16q22.1 67640–67703 RSAS protective 4 rs3785079 1.82E-05 2 0 TMCO7
Abbrevioations Chr: chromosome; kb, kilobase (according to NCBI build 36.1).
doi:10.1371/journal.pone.0030643.t001
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Despite the obvious question that the identification of LCT
brings, it should not be a completely unexpected observation. LCT
could legitimately have a role in the etiology of schizophrenia.
Galactose produced through LCT has been implicated in
neuronal development, learning and memory [20]. 2-deoxy-D-
galactose has been implicated in long term potentiation [21], thus
it is closely related to learning and memory functions [22].
Further, LCT has displayed evidence for association with
schizophrenia in a genome-wide association study [23].
In addition to the protein coding genes identified, we noted two
micro RNAs within our regions of interest. Further analysis through
in silico techniques showed that molecules predicted to be targets of
MIR620 are significantly enriched for genes previously implicated
in bipolar disorder and nervous system development. This suggests
that MIR620 could play an important role in the brain and
potentially in the etiology of mental illnesses through dysregulation
of numerous genes involved in the normal functioning of the brain.
It should also be noted that, LCT is one of the predicted target
molecules of MIR620. It had previously been shown that expression
levels of LCT are correlated with DISC1 genotype [10]. The
expression levels of LCT significantly increased in individuals
carrying a DISC1 variant that also correlated with reduced DISC1
gene expression [10]. These provide further evidence that LCT
could play a role in major mental illness. A role for MIR128-1 in
neurological and psychological disorders has been suggested,
potentially through Reelin signaling in neurons [24]. Thus, it is
possible that MIR128-1 has a role in the etiology of mental illness.
However, in our analysis of target enrichments the first biological
function relating to the brain is the 158th enriched category.
Therefore, we can not lend support to this hypothesis.
In this study we have taken an exploratory approach to
identifying new candidate genes in genetic studies of psychosis.
Pathway analysis has guided the identification of genes of interest
in regions displaying suggestive association evidence. However, the
real strength of the approach lies in the fact that it identifies
biologically plausible candidate genes that would not have been
detected without conditioning the data on a previous finding.
Naturally, the approach is predominantly hypothesis generating,
therefore the genes identified here should be verified in other
samples for a role in mental illness. Yet, the presence of several
associating SNPs within the regions of interest and the similar
effects seen on both RSAS and RPAS add internal support for the
involvement of these loci in the psychosis proneness. The use of a
quantitative measure of psychosis proneness assessed in a large
population cohort already makes the findings more generalized to
a broad selection of disorders related to psychoses and psychosis
proneness. That the effects of these molecules were not observed in
the unconditioned analysis, suggest that these molecules may have
an effect dependent on DISC1, further increasing the importance
of the DISC1 related pathway in the etiology of mental illness.
Materials and Methods
Study sample
The Northern Finland Birth Cohort 1966 (NFBC66) sample has
been described in detail elsewhere [3]. The study was started in
1965 in the two northernmost provinces of Finland (Oulu and
Lapland). Data on the individuals born into this cohort and on
their mothers and fathers were collected from the 24th gestational
week. Altogether, 12 231 children were born into the cohort, and
12 058 of them were live born [25]. The cohort has been
supplemented by data collected by postal questionnaires at the
ages of 1, 14, and 31 years, by hospital records and national
register data, and by a physical examination at the age of 31 years.
The phenotypic data analyzed in this study was included in a
questionnaire offered to individuals at the 31-year follow-up. A
total of 4651 individuals completed the questionnaire and
provided a DNA sample along with written informed consent [3].
The scales that were included in the present study were the scales
with which we previously detected association to DISC1. These
scales were the Revised Social Anhedonia Scale (RSAS) [26,27], and
the Revised Physical Anhedonia Scale (RPAS) [28]. The psycho-
metric properties of these scales in this specific setting have been
previously reported [29,30]. Previously it has been shown that social
anhedonia, after controlling for the effects of the other psychosis
proneness measures, independently and most clearly predicted later
Figure 1. Illustration of how the identified molecules are relevant within the DISC1 pathway.
doi:10.1371/journal.pone.0030643.g001
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schizophrenia-spectrum personality disorders, social dysfunction and
poor quality of relationships [31]. The Physical Anhedonia Scale was
suggested to be a less effective tool for estimation of psychosis
proneness [5]. However, in recent reports both physical anhedonia
and social anhedonia have shown to be adequate indicators for later
schizophrenia spectrum disorders [32] and psychosis [33].
The sample was stratified based on genotypes for SNPs under
interplay that had previously been identified as associating to
RSAS and RPAS. The minor allele of SNP rs821577, independent
of the other markers, was significantly associated with higher
scores on RSAS and RPAS [3]; that is individuals carrying this
minor allele expressed significantly more anhedonic features. This
SNP previously displayed evidence for association through
increasing risk to bipolar disorder [2]. Thus, this variant is
referred to as the risk variant. Marker rs821633 displayed a
significant score reducing effect on these scales when conditioned
on the absence of the minor alleles at rs821577 and rs1538979 [3].
This combination of alleles was also previously shown to reduce
risk to both schizophrenia and bipolar disorder [2]. Thus, this
combination of alleles is referred to as protective. Individuals
carrying neither of these alleles were considered as carrying a
neutral genotype. The number of individuals that carried risk,
protective and neutral variants were 3 054, 962 and 545,
respectively. Additionally, a non-stratified analysis was performed
where DISC1 variant status was used as a covariate. Due to inter-
dependence between sex and the outcome measures, all the
analyses were covariated for sex [34]. The phenotypic character-
istics of the sample and the subsamples are presented in Table 2.
Due to the test variables being slightly right skewed, logarithmic
transformation was performed for each variable. After transfor-
mation, both RSAS and RPAS reached normality.
Genotyping methods
Genotyping was performed using the Illumina Infinum Human
CNV370-Duo marker set. SNPs with a success rate,95% or minor
allele frequency (MAF) ,0.05 and individuals with genotyping
success rate ,95% were excluded from the analyses. After quality
controls 331 307 SNPs out of 339 054 SNPs and 5 251 individuals
were included in the analyses. Out of these individuals, phenotypic
information was available for 4 561 individuals.
Statistical methods
Genome-wide association analysis was performed using PLINK
(version 1.05) [35] and its additive linear regression model. To
account for multiple testing, the generally accepted limit of P,5E-8
for genome-wide significance was used as a cut off value [36].
Further, the significance levels were evaluated using QQ plots. No
notable deviation from the significance level expected by chance
was observed (for further information see Figure S3). In addition to
single SNPs, as an empirical limit for suggestive evidence of
association, we considered clusters of $3 SNPs within a distance of
300 kb that associated with P,1E-4. These were considered as
possible regions of interest and were followed by identifying the
closest coding and non-coding genes located in UCSC Genome
Browser (NCBI Build 36.1) (for details Supplementary Information).
Coding genes in these regions of interest were analyzed for prior
evidence for a role in psychiatric illness using UCSC Genome
Browser (NCBI Build 36.1) and SZGene [37]. Further, a linkage
disequilibrium analysis for the suggestive SNPs was performed using
program Haploview [38]. The average r2of neighboring SNPs was
0.74 suggesting that they are relatively independent of each other
and thus could be considered as internal replication of these regions,
as a means to reduce the possibility of false positive observations.
Pathway analysis
The relevance of the coding genes to the DISC1 pathway was
studied through Ingenuity Pathway Analysis tools (IPA) (Ingenui-
tyH Systems, www.ingenuity.com). All direct interactions between
the identified genes with DISC1 and its IPA annotated interactors
were studied. These interaction types are predominantly protein-
protein binding and regulation of gene expression. When
microRNAs were indentified, the predicted miRNA target sites
were obtained through MicroCosm Targets (formerly miRBase
Targets) [39]. This target gene list was then compared against
IPA’s own list of known genes to determine if there was significant
enrichment in specific functions or pathways.
Ethics statement
This study has followed the declaration of Helsinki and its
amendments in full [40]. The study has been proved by Ministry
of Social Affairs (Finland) and Ethical Committee of The Northern
Ostrobothnia Hospital District. All the participants in the study
have provided their written informed consent.
Supporting Information
Figure S1 Manhattan plots for all the tested models:
RPAS risk (a), RPAS protective (b), RPAS neutral (c), RPAS
covariated (d), RSAS risk (e), RSAS protective (f), RSAS neutral
(g), RSAS covariated (h). Blue line corresponds to P= 10 E-4. The
clusters with $3 SNPs with P,10E-4 are marked with asterisk (*).
(DOC)
Figure S2 Illustration of how predicted target molecules
of MIR620 that showed enrichment in bipolar disorder
and psychological disorder have been related to etiolo-
gies of schizophrenia and psychosis.
(DOC)
Table 2. Descriptive statistics on the outcome measures in the study sample.
Variable RSAS RPAS
Sample Whole Risk Neutral Protective Whole Risk Neutral Protective
N 4556 3049 545 962 4556 3049 545 962
Meana 9.5 9.64 9.52 8.97 15.12 15.28 15.04 14.53
95% CI of mean 9.34–9.66 9.44–9.84 9.02–10.03 8.62–9.33 14.91–15.32 15.02–15.53 14.40–15.68 14.08–14.97
SD 5.53 5.51 5.62 5.51 7.08 7.12 7.12 6.95
aRange for RSAS 0–40, range for RPAS 0–61. Abbreviations: RSAS: Revised Social Anhedonia Scale, RPAS: Revised Physical Anhedonia Scale, N: the number of individuals,
CI: confidence interval, SD: standard deviation.
doi:10.1371/journal.pone.0030643.t002
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Figure S3 The schematics show the QQ plots for the
observed 2log10 P-values versus those expected by
change for Revised Social Anhedonia Scale. (a) and Revised
Physical Anhedonia Scale (b) risk (1), protective (2), neutral (3) and
covariated (4) models.
(DOC)
Table S1 Summary of the SNPs displaying P-valu-
es,10E-4 and located within clusters of three such
SNPs. For all the SNPs, the closest gene and the shortest
distance to the gene in base pairs are indicated.
(XLS)
Table S2 Summary of the SNPs with P,1E-4 within the
loci with biological relevance for schizophrenia and the
DISC1 pathway.
(XLS)
Table S3 Table of enriched IPA categories and func-
tions for the gene targets of MIR620.
(XLS)
Table S4 Table of enriched IPA categories and func-
tions for the gene targets of MIR-128-1.
(XLS)
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